The Multi-Cancer Early Detection (MCED) Market refers to the growing sector focused on innovative diagnostic technologies that can identify multiple cancers at early stages using a single test. These tests typically analyze biomarkers like circulating tumor DNA (ctDNA) or proteins in blood samples, ...